These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 6515071

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Arterial hypertension secondary to the application of 9-alpha-fluoroprednisolone ointments].
    Arnal JM, Moneo MI, Loris C.
    An Esp Pediatr; 1987 Jan; 26(1):65-6. PubMed ID: 3826948
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Hypertension and hypokalemia caused by a nasal spray containing fluorprednisolone acetate].
    Maiorano G, Loiacono N, Di Bello V, Contursi V, Castelnuovo F, Albano O.
    Boll Soc Ital Cardiol; 1981 Jan; 26(5):465-71. PubMed ID: 7340877
    [No Abstract] [Full Text] [Related]

  • 5. [Hypermineralcorticism syndrome secondary to topical application of 9-alpha-fluoroprednisolone (author's transl)].
    Vasconez F, Pérez-Garcia R, Olivas E, Bolívar JE, Valderrábano F.
    Med Clin (Barc); 1980 Dec 15; 75(10):430-4. PubMed ID: 7464329
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Pseudoprimary aldosteronism from the topical application of 9-alpha-fluorprednisolone to the skin.
    Montoliu J, Botey A, Trilla A, Revert L.
    Clin Nephrol; 1984 Nov 15; 22(5):262-6. PubMed ID: 6394185
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Pseudohyperaldosteronism due to application of an antihemorrhoid cream.
    Marin F, González Quintela A, Moya M, Suárez E, de Zárraga M.
    Nephron; 1989 Nov 15; 52(3):281-2. PubMed ID: 2739869
    [Abstract] [Full Text] [Related]

  • 11. [Hypokalemic alkalosis due to 9-alpha-fluoroprednisolone locally applied in pemphigus vulgaris].
    Scarpa C, Gentilli G.
    G Ital Dermatol Venereol; 1983 Nov 15; 118(3):179-81. PubMed ID: 6546245
    [No Abstract] [Full Text] [Related]

  • 12. Factitious hypertension with mineralocorticoid excess in an infant.
    De Stefano P, Bongo IG, Borgna-Pignatti C, Severi F.
    Helv Paediatr Acta; 1983 May 15; 38(2):185-9. PubMed ID: 6874387
    [Abstract] [Full Text] [Related]

  • 13. [Hypokalemic myopathy caused by fluoroprednisolone in a nasal spray. Observations 2 cases].
    Cantello R, Bergamini L, Delsedime M, Durelli L, Troni W, Gilli M, Cocito D.
    Minerva Med; 1983 Jun 16; 74(25):1463-7. PubMed ID: 6856155
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Excess mineralocorticoid syndrome secondary to nasal sprays containing 9 alpha-fluoroprednisolone].
    Foresti V, Parisio E, Ricci G.
    Minerva Med; 1987 Sep 15; 78(17):1305-11. PubMed ID: 2444906
    [Abstract] [Full Text] [Related]

  • 16. The etiology of a syndrome of factitious mineralocorticoid excess: a steroid-containing nasal spray.
    Funder JW, Adam WR, Mantero F, Kraft N, Ulick S.
    J Clin Endocrinol Metab; 1979 Dec 15; 49(6):842-6. PubMed ID: 92477
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.